MIRM
Mirum Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$96.97
+11.42%Leverage
- Debt / equity
- -13.67x
- Net debt / equity
- -9.19x
- Debt / assets
- 0.72x
- Debt / EBITDA
- -0.88x
- Net debt / EBITDA
- -0.59x
Liquidity & coverage
- Current ratio
- 2.07x
- Quick ratio
- 1.98x
- Cash ratio
- 1.32x
- Interest coverage
- -20.67x
- EBITDA / interest
- -102.80x
- Working capital
- $303.5M
Cash & dividend
- FCF / debt
- -0.37x
- Cash flow / debt
- -0.37x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026